Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 15.5B | 14.8B | 11.6B | 13.9B |
Cost of revenue | 9.5B | 12.4B | 10.2B | 11.8B |
Gross profit | 6.1B | 2.3B | 1.4B | 2.1B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 1.9B | 1.5B | 492M | 942.7M |
Operating income | 2.3B | -788M | -533.1M | -261.5M |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 236.1M | 240.5M | 259.7M | 292.7M |
Other income expense | — | — | — | — |
Pretax income | 2.2B | -1.0B | -756.9M | -507.2M |
Tax provision | -2.4M | -2.3M | -2.1M | 54.5M |
Net income | 2.2B | -1.0B | -756.3M | -670.5M |
Basic EPS | — | -0.8 | -0.6 | -0.5 |
Diluted EPS | — | -0.8 | -0.6 | -0.5 |
Basic average shares | — | 1.2B | 1.2B | 1.3B |
Diluted average shares | — | 1.2B | 1.2B | 1.3B |
EBITDA | 2.9B | -233.4M | 45.9M | 323.3M |
Net income from continuing op. | — | — | — | — |
Minority interests | 1.8M | 2.3M | 2.3M | 5.6M |
Preferred stock dividends | 0 | 0 | 0 | 0 |